An open-label extension study of the safety of long-term administration of sirolimus (Rapamune) in solid organ transplant recipients
Phase of Trial: Phase III
Latest Information Update: 25 Aug 2009
At a glance
- Drugs Sirolimus (Primary)
- Indications Transplant rejection
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Wyeth
- 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2009 Actual end date (1 Aug 2004) and actual patient number (769) added as reported by ClinicalTrials.gov.
- 16 Oct 2006 New trial record.